Tags : IPO

Principia Biopharma files for Initial Public Offering in the US

Shots: Principia files IPO with $86mn having ticker PRNB Principia’s lead product PRN1008 (BTKi) with Ph III & II for pemphigus and immune thrombocytopenic purpura respectively In 2017, Principia collaborated with AbbVie for oral immunoproteasome inhibitors and with Sanofi for development of PRN2246 (BTKi Click here to read full press release/ article | Ref: Principia Biopharma | Image:  […]Read More

Lilly’s spinoff Elanco Animal Health files IPO

  Shots:  Elanco files a registration with U.S. SEC for potential IPO, expected to end by 201 Offering an ownership of <20% shares of Elanco for Lilly The no. of shares as well as the price range to be offered, has not yet disclosed Click here to read full press release/ article | Ref: Lilly | […]Read More